AKT1 and cancer: First, PI3K-Akt is considered antiapoptotic kinase signaling pathway since it was previously found to be active in several human cancers and its inappropriate activation or inhibition resulted in blocked proliferation and enhanced sensitivity toward cytotoxic agents.